Related Experiment Videos

[Treatment of meningococcal sepsis]

E Kasal1, I Chytra, V Cervený

  • 1Anesteziologicko-resuscitacní klinika FN, Plzen, Infekcní klinika FN.

Abstract

Insights

Early, complex treatment of invasive meningococcal disease caused by a new Neisseria meningitidis group C strain significantly improves survival rates. A standardized treatment protocol is crucial for managing this severe sepsis.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Intensive Care Medicine

Background:

  • Increased incidence of invasive meningococcal disease and sepsis caused by Neisseria meningitidis group C (2a: P 1,2) observed in the Czech Republic.
  • The West region reported the highest incidence in 1994.
  • Ten critically ill patients were treated at the Department of Anaesthesiology and Intensive Care.

Purpose of the Study:

  • To present the principles of treating invasive meningococcal disease caused by a new Neisseria meningitidis group C strain.
  • To highlight the importance of early and complex therapeutic interventions.

Main Methods:

  • Treatment of 10 patients (8 male, 2 female; average age 11 years) with invasive meningococcal disease.
  • Strain identification performed in 9 patients.
  • Standardized complex treatment protocol including artificial ventilation, circulation support, antibiotics (Ceftriaxone and benzylpenicillin), immunoglobulins, fresh frozen plasma, heparin, fibrinogen, and antithrombin III.

Main Results:

  • All patients presented with typical clinical symptoms.
  • Average intensive care unit stay was 5 days.
  • Overall survival rate in the treated group was 70%.

Conclusions:

  • Early initiation of complex therapy is critical for successful outcomes in invasive meningococcal disease.
  • A uniform treatment protocol, widely disseminated, can enhance patient survival chances.

Related Concept Videos